275 related articles for article (PubMed ID: 35206475)
1. Adenomyosis as a Risk Factor for Myometrial or Endometrial Neoplasms-Review.
Szubert M; Kozirog E; Wilczynski J
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206475
[TBL] [Abstract][Full Text] [Related]
2. Adenomyosis and Endometrial Cancer: Literature Review.
Habiba M; Pluchino N; Petignat P; Bianchi P; Brosens IA; Benagiano G
Gynecol Obstet Invest; 2018; 83(4):313-328. PubMed ID: 29874641
[TBL] [Abstract][Full Text] [Related]
3. Adenomyosis pathogenesis: insights from next-generation sequencing.
Bulun SE; Yildiz S; Adli M; Wei JJ
Hum Reprod Update; 2021 Oct; 27(6):1086-1097. PubMed ID: 34131719
[TBL] [Abstract][Full Text] [Related]
4. Good outcome of endometrial cancer patients coexisting with adenomyosis is a result of their associated favorable clinico-pathological parameters.
Chou FW; Lee NR; Wang PH
Taiwan J Obstet Gynecol; 2023 Nov; 62(6):795-796. PubMed ID: 38008494
[No Abstract] [Full Text] [Related]
5. Endometriosis, leiomyoma and adenomyosis: the risk of gynecologic malignancy.
Verit FF; Yucel O
Asian Pac J Cancer Prev; 2013; 14(10):5589-97. PubMed ID: 24289548
[TBL] [Abstract][Full Text] [Related]
6. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis.
Liu X; Shen M; Qi Q; Zhang H; Guo SW
Hum Reprod; 2016 Apr; 31(4):734-49. PubMed ID: 26908845
[TBL] [Abstract][Full Text] [Related]
7. Endometrial cancer arising in adenomyosis versus endometrial cancer coexisting with adenomyosis: are these two different entities?
Machida H; Maeda M; Cahoon SS; Scannell CA; Garcia-Sayre J; Roman LD; Matsuo K
Arch Gynecol Obstet; 2017 Jun; 295(6):1459-1468. PubMed ID: 28444512
[TBL] [Abstract][Full Text] [Related]
8. Malignant changes in adenomyosis in patients with endometrioid adenocarcinoma.
Kucera E; Hejda V; Dankovcik R; Valha P; Dudas M; Feyereisl J
Eur J Gynaecol Oncol; 2011; 32(2):182-4. PubMed ID: 21614909
[TBL] [Abstract][Full Text] [Related]
9. Malignant changes in adenomyosis in patients with endometrial adenocarcinoma: A case series.
Mao X; Zheng W; Mao W
Medicine (Baltimore); 2017 Oct; 96(43):e8336. PubMed ID: 29069006
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis and malignant transformation of adenomyosis (review).
Koike N; Tsunemi T; Uekuri C; Akasaka J; Ito F; Shigemitsu A; Kobayashi H
Oncol Rep; 2013 Mar; 29(3):861-7. PubMed ID: 23242072
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Adenomyosis in Myometrial Invasion and Overall Survival in Endometrial Cancer.
Erkilinç S; Taylan E; Gülseren V; Erkilinç G; Karadeniz T; Bağci M; Temel O; Solmaz U; Gökçü M; Sanci M
Int J Gynecol Cancer; 2018 Jan; 28(1):145-151. PubMed ID: 29040186
[TBL] [Abstract][Full Text] [Related]
12. Pathology and Pathogenesis of Adenomyosis.
Antero MF; Ayhan A; Segars J; Shih IM
Semin Reprod Med; 2020 May; 38(2-03):108-118. PubMed ID: 33080632
[TBL] [Abstract][Full Text] [Related]
13. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer.
Matsuo K; Cahoon SS; Gualtieri M; Scannell CA; Jung CE; Takano T; Paulson RJ; Muderspach LI; Roman LD
Ann Surg Oncol; 2014 Dec; 21(13):4246-55. PubMed ID: 25001096
[TBL] [Abstract][Full Text] [Related]
14. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis.
Nascimento AF; Hirsch MS; Cviko A; Quade BJ; Nucci MR
Mod Pathol; 2003 Jan; 16(1):22-7. PubMed ID: 12527709
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical analysis of proliferative activity of endometrial and myometrial cell populations in focal and stromal adenomyosis.
Nepomnyashchikh LM; Lushnikova EL; Molodykh OP; Pichigina AK
Bull Exp Biol Med; 2013 Aug; 155(4):512-7. PubMed ID: 24143380
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of adenomyosis in endometrial cancer patients: a systematic review and meta-analysis.
Raffone A; Seracchioli R; Raimondo D; Maletta M; Travaglino A; Raimondo I; Giaquinto I; Orsini B; Insabato L; Pellicano M; Zullo F
Arch Gynecol Obstet; 2021 Jan; 303(1):47-53. PubMed ID: 33098006
[TBL] [Abstract][Full Text] [Related]
17. Effect of adenomyosis on prognosis of patients with endometrial cancer.
Şimşek E; Yıldız Ş; Karakaş S; Gündüz S; Yıldız ÖA; Özdemir İA; Yaşar L
Rev Assoc Med Bras (1992); 2023; 69(7):e20221720. PubMed ID: 37466591
[TBL] [Abstract][Full Text] [Related]
18. Immunological changes associated with adenomyosis: a systematic review.
Bourdon M; Santulli P; Jeljeli M; Vannuccini S; Marcellin L; Doridot L; Petraglia F; Batteux F; Chapron C
Hum Reprod Update; 2021 Jan; 27(1):108-129. PubMed ID: 33099635
[TBL] [Abstract][Full Text] [Related]
19. Differential immunohistochemical expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in cow uteri with adenomyosis during follicular phase.
Moreira L; de Carvalho EC; Caldas-Bussiere MC
Vet Res Commun; 2011 Jun; 35(5):261-9. PubMed ID: 21626345
[TBL] [Abstract][Full Text] [Related]
20. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
